Determination of a neuroprotective agent (S)-(+)-BMS-204352 in human, rat and dog plasma by enantioselective liquid chromatography-tandem mass spectrometry.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2004-11-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JCHROMB.2004.08.002PMID 15522709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disposition of radiolabeled BMS‐204352 in rats and dogs

  2002cited by this paper
• High performance liquid chromatographic–mass spectrometric assay for the quantitation of BMS‐204352 in dog K3EDTA plasma

  2002cited by this paper
• The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels.

  2002cited by this paper
• Effect of dose and input rate on the brain penetration of BMS‐204352 following intravenous administration to rats

  2002cited by this paper
• High performance liquid chromatographic-mass spectrometric assay for the quantitation of BMS-204352 in dog K(3)EDTA plasma.

  2002cited by this paper
• Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels

  2001cited by this paper
• Determination of metrifonate enantiomers in blood and brain samples using liquid chromatography on a chiral stationary phase coupled to tandem mass spectrometry.

  2000cited by this paper
• Enantioselective analysis of methadone in saliva by liquid chromatography-mass spectrometry.

  2000cited by this paper
• High-throughput chiral liquid chromatography/tandem mass spectrometry.

  2000cited by this paper
• Determination of the chiral isomers of CGS 26214, a synthetic thyromimetic agent, in human plasma using microbore chiral chromatography-tandem mass spectrometry.

  2000cited by this paper
• Determination of (R)- and (S)-ketoprofen in human plasma by liquid chromatography/tandem mass spectrometry following automated solid-phase extraction in the 96-well format.

  2000cited by this paper
• Incidence and occurrence of total (first-ever and recurrent) stroke.

  1999cited by this paper
• Liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry enantiomeric separation of dl-threo-methylphenidate, (Ritalin) using a macrocyclic antibiotic as the chiral selector.

  1999cited by this paper
• Determination of the enantiomers of omeprazole in blood plasma by normal-phase liquid chromatography and detection by atmospheric pressure ionization tandem mass spectrometry.

  1999cited by this paper
• Enantioselective determination of terazosin in human plasma by normal phase high-performance liquid chromatography-electrospray mass spectrometry.

  1998cited by this paper
• Validation of an LC-MS assay for the quantification of the enantiomers of Org 4428 in human plasma.

  1998cited by this paper
• Liquid chromatography–electrospray mass spectrometry method to separate and detect N-tert.-butoxycarbonyl peptides

  1998cited by this paper
• Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometry.

  1998cited by this paper
• Chiral bioanalysis by normal phase high-performance liquid chromatography-atmospheric pressure ionization tandem mass spectrometry

  1997cited by this paper

• Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.

  2009cites this paper
• Application of microbore HPLC in combination with tandem MS for the quantification of rosuvastatin in human plasma.

  2006cites this paper